Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Turgay Ulas

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|December 19, 2024
What should be the optimal dose of post-transplantation cyclophosphamide for GVHD prophylaxis in allogeneic stem cell transplantation?Turgay Ulas, Sinem Namdaroglu, Ipek Yonal Hindilerden, et al.
Journal of Chemotherapy (Florence, Italy)|May 22, 2023
Real-world data on the effectiveness and safety of Ixazomib-Lenalidomide-Dexamethasone therapy in relapsed/refractory multiple myeloma patients: a multicenter experience in TurkeyMehmet Bakırtaş, Mehmet Sinan Dal, Tuğçe Nur Yiğenoğlu, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|September 26, 2021
Pralatrexate experience in PTCL: A multicenter retrospective study from TurkeyMehmet Sinan Dal, Alparslan Merdin, Mehmet Ali Erkurt, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|April 27, 2026
Outcomes of Brentuximab Vedotin Monotherapy in Refractory/Relapsed Classical Hodgkin's Lymphoma: A Multi-Center Retrospective Study on Survival and SafetyMehmet Bakirtas, Ipek Yonal Hindilerden, Bahar Uncu Ulu, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 11, 2021
The Real-World Experience With Single Agent Ibrutinib in Relapsed/Refractory CLLSeval Akpinar, Mehmet Hilmi Dogu, Serhat Celik, et al.
Annals of Hematology|February 20, 2026
Assessment of characteristics and treatment patterns of adult patients with acquired aplastic anemia in Turkiye (PLANE-TR)Eren Gunduz, Turgay Ulas, Fahir Ozkalemkas, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|February 26, 2023
International Forum: The Turkish perspective on apheresis activity: The Turkish apheresis registry reportDuzgun Ozatli, Aslı Odabaşı Giden, Mehmet Ali Erkurt, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|May 1, 2019
The Turkish experience with therapeutic plasma exchange: A national surveySerdal Korkmaz, Serife Solmaz Medeni, Fatih Demirkan, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|December 19, 2024
What should be the optimal dose of post-transplantation cyclophosphamide for GVHD prophylaxis in allogeneic stem cell transplantation?Turgay Ulas, Sinem Namdaroglu, Ipek Yonal Hindilerden, et al.
Journal of Chemotherapy (Florence, Italy)|May 22, 2023
Real-world data on the effectiveness and safety of Ixazomib-Lenalidomide-Dexamethasone therapy in relapsed/refractory multiple myeloma patients: a multicenter experience in TurkeyMehmet Bakırtaş, Mehmet Sinan Dal, Tuğçe Nur Yiğenoğlu, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|September 26, 2021
Pralatrexate experience in PTCL: A multicenter retrospective study from TurkeyMehmet Sinan Dal, Alparslan Merdin, Mehmet Ali Erkurt, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|April 27, 2026
Outcomes of Brentuximab Vedotin Monotherapy in Refractory/Relapsed Classical Hodgkin's Lymphoma: A Multi-Center Retrospective Study on Survival and SafetyMehmet Bakirtas, Ipek Yonal Hindilerden, Bahar Uncu Ulu, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 11, 2021
The Real-World Experience With Single Agent Ibrutinib in Relapsed/Refractory CLLSeval Akpinar, Mehmet Hilmi Dogu, Serhat Celik, et al.
Annals of Hematology|February 20, 2026
Assessment of characteristics and treatment patterns of adult patients with acquired aplastic anemia in Turkiye (PLANE-TR)Eren Gunduz, Turgay Ulas, Fahir Ozkalemkas, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|February 26, 2023
International Forum: The Turkish perspective on apheresis activity: The Turkish apheresis registry reportDuzgun Ozatli, Aslı Odabaşı Giden, Mehmet Ali Erkurt, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|May 1, 2019
The Turkish experience with therapeutic plasma exchange: A national surveySerdal Korkmaz, Serife Solmaz Medeni, Fatih Demirkan, et al.
Pageof 6